https://www.selleckchem.com/pr....oducts/BafilomycinA1
IBD patients on biologics can have higher risk of developing such complications because of their decreased ability to fight infections. Although the risk of serious infections declines significantly after the first year of using biologics, physicians should keep a low threshold for investigating symptomatic patients for serious infections, as they require prompt intervention. Despite the potential complications from using biologics, the benefits of this therapy in IBD patients outweigh the risks. Laparoscopic pancreaticoduodenecto
Like
Comment
Share
